Hui-Hua Li Selected Research

C-Reactive Protein

1/2019	The relationship between Plasma Markers and Essential Hypertension in Middle-aged and Elderly Chinese Population: A Community Based Cross-sectional Study.
1/2019	A correlational study between serum asymmetric dimethylarginine level and impaired glucose tolerance patients associated with obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Hua Li Research Topics

Disease

39	Inflammation (Inflammations) 01/2024 - 01/2011
30	Fibrosis (Cirrhosis) 01/2024 - 09/2012
27	Hypertension (High Blood Pressure) 01/2023 - 04/2002
24	Cardiomegaly (Heart Hypertrophy) 02/2024 - 10/2004
20	Hypertrophy 01/2022 - 10/2004
14	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 06/2013
11	Heart Failure 12/2023 - 01/2011
11	Heart Diseases (Heart Disease) 12/2023 - 10/2013
10	Atrial Fibrillation 01/2023 - 01/2018
9	Reperfusion Injury 10/2023 - 03/2011
8	Myocardial Infarction 12/2023 - 01/2013
7	Neoplasms (Cancer) 01/2022 - 10/2015
6	Infarction (Infarctions) 12/2023 - 08/2014
6	Atherosclerosis 01/2020 - 03/2014
5	Atrial Remodeling 01/2023 - 01/2019
5	Abdominal Aortic Aneurysm 05/2019 - 01/2012
5	Ischemia 01/2018 - 03/2011
4	Sepsis (Septicemia) 03/2024 - 01/2022
4	Hypoxia (Hypoxemia) 10/2023 - 01/2013
4	Cardiomyopathies (Cardiomyopathy) 02/2023 - 10/2015
4	Vascular Remodeling 01/2022 - 11/2016
4	Insulin Resistance 05/2019 - 07/2006
3	Vascular System Injuries 10/2022 - 03/2016
3	Necrosis 01/2020 - 04/2011
3	Cardiotoxicity 01/2016 - 07/2015
2	Cognitive Dysfunction 02/2024 - 12/2021
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2023 - 02/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2023 - 10/2021
2	Cardiac Edema 01/2022 - 01/2021
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 04/2014
2	Edema (Dropsy) 01/2022 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 02/2017
2	Cicatrix (Scar) 01/2020 - 04/2016
2	Hypertensive Retinopathy 01/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

36	Angiotensin IIIBA 02/2024 - 10/2011
20	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2004
11	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2023 - 03/2011
11	Superoxides (Superoxide)IBA 10/2023 - 11/2011
11	CytokinesIBA 02/2022 - 11/2011
8	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2024 - 11/2011
7	UbiquitinIBA 01/2022 - 10/2004
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2011
7	CollagenIBA 01/2017 - 10/2011
5	SaltsIBA 01/2023 - 11/2016
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2011
5	Apolipoproteins E (ApoE)IBA 12/2021 - 10/2015
5	NF-kappa B (NF-kB)IBA 01/2020 - 11/2011
5	Ligases (Synthetase)IBA 01/2016 - 10/2004
4	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2023 - 11/2016
4	Acetates (Acetic Acid Esters)FDA Link 01/2023 - 11/2016
4	Connexin 43 (Connexin43)IBA 01/2023 - 01/2018
4	Neurotransmitter Agents (Neurotransmitter)IBA 10/2022 - 11/2011
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 07/2006
4	AngiotensinsIBA 01/2022 - 03/2014
4	Messenger RNA (mRNA)IBA 12/2021 - 09/2006
4	CalcineurinIBA 01/2021 - 10/2004
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2006
4	Chemokine ReceptorsIBA 10/2020 - 11/2016
4	Desoxycorticosterone Acetate (DOCA)FDA Link 12/2019 - 11/2016
4	Interleukin-6 (Interleukin 6)IBA 05/2019 - 09/2012
4	salicylhydroxamic acid (SHAM)IBA 01/2017 - 11/2011
3	Protein Kinases (Protein Kinase)IBA 12/2023 - 07/2013
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023 - 01/2019
3	FluorineIBA 10/2022 - 08/2017
3	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2011
3	LipidsIBA 10/2021 - 01/2014
3	LDN 57444IBA 10/2020 - 01/2020
3	SB 225002IBA 10/2020 - 12/2019
3	Neutralizing AntibodiesIBA 01/2020 - 03/2014
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 09/2012
3	Gallic AcidIBA 01/2020 - 01/2019
3	VO-OHpicIBA 01/2020 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2019 - 11/2014
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2015
3	Small Interfering RNA (siRNA)IBA 01/2013 - 10/2004
2	Angiotensin-Converting Enzyme 2IBA 01/2024 - 12/2023
2	Phosphotransferases (Kinase)IBA 12/2023 - 01/2023
2	epoxomicinIBA 10/2023 - 01/2022
2	TrypsinIBA 07/2023 - 01/2018
2	Protein Isoforms (Isoforms)IBA 07/2023 - 11/2011
2	IntegrinsIBA 02/2023 - 01/2023
2	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2022
2	NADP (NADPH)IBA 01/2023 - 11/2016
2	Retinaldehyde (Retinal)IBA 10/2022 - 01/2018
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2022 - 11/2007
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2022 - 01/2021
2	FluoridesIBA 12/2021 - 08/2017
2	Vascular Endothelial Growth Factor CIBA 01/2021 - 01/2020
2	Deubiquitinating EnzymesIBA 10/2020 - 01/2020
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 11/2016
2	4(4- (5- nitro- furan- 2- ylmethylene)- 3,5- dioxo- pyrazolidin- 1- yl)- benzoic acid ethyl esterIBA 01/2020 - 10/2018
2	Chymotrypsin FDA Link 01/2020 - 01/2020
2	CholesterolIBA 01/2020 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2018
2	c-Mer Tyrosine KinaseIBA 01/2020 - 01/2020

Therapy/Procedure

6	Therapeutics 01/2023 - 08/2009
3	Ligation 02/2023 - 11/2011
2	Anesthesia 02/2024 - 05/2012
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2024 - 03/2014
2	Punctures 02/2023 - 01/2022